Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
…, D Etemadmoghadam, B Locandro, N Traficante… - Clinical cancer …, 2008 - AACR
Purpose: The study aim to identify novel molecular subtypes of ovarian cancer by gene
expression profiling with linkage to clinical and pathologic features. Experimental Design: …
expression profiling with linkage to clinical and pathologic features. Experimental Design: …
Whole–genome characterization of chemoresistant ovarian cancer
…, K Strachan, P Waring, W Azar, C Mitchell, N Traficante… - Nature, 2015 - nature.com
Patients with high-grade serous ovarian cancer (HGSC) have experienced little
improvement in overall survival, and standard treatment has not advanced beyond platinum-based …
improvement in overall survival, and standard treatment has not advanced beyond platinum-based …
Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas
…, B Locandro, K Alsop, YE Chiew, N Traficante… - Clinical cancer …, 2009 - AACR
Purpose: A significant number of women with serous ovarian cancer are intrinsically refractory
to platinum-based treatment. We analyzed somatic DNA copy number variation and gene …
to platinum-based treatment. We analyzed somatic DNA copy number variation and gene …
[HTML][HTML] Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
…, KK Lin, TC Harding, N Traficante… - Nature …, 2018 - nature.com
Accurately identifying patients with high-grade serous ovarian carcinoma (HGSOC) who
respond to poly(ADP-ribose) polymerase inhibitor (PARPi) therapy is of great clinical importance…
respond to poly(ADP-ribose) polymerase inhibitor (PARPi) therapy is of great clinical importance…
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
…, PT Hamilton, J Hendley, YE Chiew, N Traficante… - Nature …, 2022 - nature.com
Fewer than half of all patients with advanced-stage high-grade serous ovarian cancers (HGSCs)
survive more than five years after diagnosis, but those who have an exceptionally long …
survive more than five years after diagnosis, but those who have an exceptionally long …
Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors
…, L Simms, B Locandro, S Fereday, N Traficante… - Molecular cancer …, 2008 - AACR
Approximately, 10% to 15% of serous ovarian tumors fall into the category designated as
tumors of low malignant potential (LMP). Like their invasive counterparts, LMP tumors may be …
tumors of low malignant potential (LMP). Like their invasive counterparts, LMP tumors may be …
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D
…, J Dennis, DD Bowtell, N Traficante… - JNCI: Journal of the …, 2020 - academic.oup.com
Background The purpose of this study was to estimate precise age-specific tubo-ovarian
carcinoma (TOC) and breast cancer (BC) risks for carriers of pathogenic variants in RAD51C …
carcinoma (TOC) and breast cancer (BC) risks for carriers of pathogenic variants in RAD51C …
Siah ubiquitin ligase is structurally related to TRAF and modulates TNF-α signaling
G Polekhina, CM House, N Traficante… - Nature structural …, 2002 - nature.com
Members of the Siah (seven in absentia homolog) family of RING domain proteins are
components of E3 ubiquitin ligase complexes that catalyze ubiquitination of proteins. We have …
components of E3 ubiquitin ligase complexes that catalyze ubiquitination of proteins. We have …
A binding motif for Siah ubiquitin ligase
…, HL Huang, G Wiche, N Traficante… - Proceedings of the …, 2003 - National Acad Sciences
The Drosophila SINA (seven in absentia) protein and its mammalian orthologs (Siah, seven
in absentia homolog) are RING domain proteins that function in E3 ubiquitin ligase …
in absentia homolog) are RING domain proteins that function in E3 ubiquitin ligase …
[HTML][HTML] The molecular origin and taxonomy of mucinous ovarian carcinoma
…, AN Stephens, N Thio, MC Torres, N Traficante… - Nature …, 2019 - nature.com
Mucinous ovarian carcinoma (MOC) is a unique subtype of ovarian cancer with an uncertain
etiology, including whether it genuinely arises at the ovary or is metastatic disease from …
etiology, including whether it genuinely arises at the ovary or is metastatic disease from …